CD8A and neoplasm: Herein, we extend these observations by showing that 6 Gy radiation combined with the NSAID INDO augmented cGAS/STING1, type I IFNs, and cytolytic CD8+ T cells; this augmentation appeared to restore immune surveillance, limit tumor growth and metastatic burden, and improve survival in the aggressive 4T1 TNBC model.